Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy (scientific article)

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

Q27002495

APACHE II: a severity of disease classification system

Q29547729

The CTX-M beta-lactamase pandemic.

Q30356558

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

Q30818147

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems

Q33623060

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Q33945413

Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates

Q33963663

Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours.

Q33973352

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.

Q34107684

Hospital-acquired infections due to gram-negative bacteria

Q34114983

Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia

Q34190425

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention

Q34190800

Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients

Q34265137

Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.

Q34327857

Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae

Q41936281

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

Q42167308

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

Q42287246

Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae

Q42413051

Rapid identification of bla KPC-possessing Enterobacteriaceae by PCR/electrospray ionization-mass spectrometry

Q42732606

Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

Q42799124

Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae

Q43085392

Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents

Q44086861

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

Q44436393

Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards

Q44580618

Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient

Q44821919

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

Q44943295

Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.

Q45223414

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

Q34351978

Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study.

Q34522207

Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants

Q34596735

Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae

Q34648809

Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.

Q34678004

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

Q34708485

Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Q34726682

Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies

Q34869292

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

Q34969565

RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis

Q34999634

Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia

Q34999856

Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae

Q35005216

Rapid detection of blaKPC carbapenemase genes by internally controlled real-time PCR assay using bactec blood culture bottles

Q35140084

Detection of carbapenemase activity directly from blood culture vials using MALDI-TOF MS: a quick answer for the right decision

Q35145706

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

Q35867414

Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC).

Q36171410

Detection of extended-spectrum β-lactamase and Klebsiella pneumoniae Carbapenemase genes directly from blood cultures by use of a nucleic acid microarray

Q36172336

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

Q36357629

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

Q36361921

Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases

Q36424079

Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae

Q36785821

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

Q36937529

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

Q37091253

Clinical significance of extended-spectrum beta-lactamases.

Q37291354

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

Q37624439

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

Q37677832

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Q37884104

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

Q38002952

Strategies for identification of carbapenemase-producing Enterobacteriaceae

Q38056079

Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections

Q38145311

Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae

Q38165138

Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates

Q38475591

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

Q50523195

Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia.

Q51135821

Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota.

Q54442661

Performance in detection and reporting beta-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories.

Q54465752

Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010

Q56909843

An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase

Q59245522

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae

Q59661000

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

Q64131374

CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections

Q64135964

A global goodness-of-fit statistic for Cox regression models

Q73796898

Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia

Q78408808

Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY

Q80301574

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment

Q84148237

New rapid methods cannot replace the current method to diagnose bloodstream infections

Q87329481

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012

Q87444358

P3931

Wolters Kluwer Health

copyrighted

issue

language of work or name

English

Q1860

P921

main subject

antibiotic

Q12187

Klebsiella pneumoniae

Q132592

bacteremia

Q650912

klebsiellosis

Q3197774

inappropriate prescribing

Q65591006

P5008

on focus list of Wikimedia project

ScienceSource

Q55439927

P304

page(s)

298-309

P577

publication date

2014-10-01

P1433

published in

Medicine

Q15716652

P1476

title

Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy

P478

volume

Reverse relations

cites work (P2860)

Q57300025	A Fatal Bacteremia Caused by Hypermucousviscous KPC-2 Producing Extensively Drug-Resistant K64-ST11 in Brazil
Q37405155	A new assay for the simultaneous identification and differentiation of Klebsiella oxytoca strains
Q37288234	Allogeneic stem cell transplantation in a blast-phase chronic myeloid leukemia patient with carbapenem-resistant Klebsiella pneumoniae tricuspid valve endocarditis: A case report
Q40701338	Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy
Q40479700	Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Q52359664	Biofilm Formation in Klebsiella pneumoniae Bacteremia Strains Was Found to be Associated with CC23 and the Presence of wcaG.
Q49816620	Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis
Q36076066	Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Q41004466	Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
Q40822047	Draft Genome Sequences of Two Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Strains Causing Bloodstream Infections
Q37422089	Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality
Q33857498	Extensively Drug-Resistant Klebsiella pneumoniae Causing Nosocomial Bloodstream Infections in China: Molecular Investigation of Antibiotic Resistance Determinants, Informing Therapy, and Clinical Outcomes.
Q40346725	Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients
Q49711959	High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
Q90609929	IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections
Q38816907	Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance
Q59135433	In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMAR
Q93211674	Klebsiella pneumoniae infection biology: living to counteract host defences
Q64135930	Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection
Q40342728	Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
Q42361199	Multidrug Resistant Enteric Bacterial Pathogens in a Psychiatric Hospital in Ghana: Implications for Control of Nosocomial Infections
Q26799580	New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies
Q38990171	Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study
Q36402480	Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.
Q38829314	Reinfection and relapse of recurrent bacteremia caused by Klebsiella pneumoniae in a medical center in Taiwan
Q47575312	Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
Q40189852	Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study
Q40072899	Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China
Q58130941	Sepsis caused by multidrug-resistant klebsiella pneumoniae infection in a 23-year-old burn patient: case report and literature review
Q53687293	The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms.
Q51784042	Tracking Multidrug-Resistant Klebsiella pneumoniae from an Italian Hospital: Molecular Epidemiology and Surveillance by PFGE, RAPD and PCR-Based Resistance Genes Prevalence.